TANDEM DIABETES CARE INC (TNDM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 400M 800M 1.2B Q3 '21: 660.9M Q4 '21: 702.8M Q1 '22: 737.7M Q2 '22: 765.8M Q3 '22: 790.7M Q4 '22: 801.2M Q1 '23: 794.7M Q2 '23: 790.3M Q3 '23: 771.4M Q4 '23: 747.7M Q1 '24: 770M Q2 '24: 796M Q3 '24: 854.4M Q4 '24: 940.2M Q1 '25: 983M Q2 '25: 1B Q3 '25: 1B Q4 '25: 1B Q1 '26: 1B Q2 '26: 1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 200M 400M 600M Q3 '21: 353M Q4 '21: 376.2M Q1 '22: 394M Q2 '22: 403.5M Q3 '22: 411.2M Q4 '22: 413M Q1 '23: 404.8M Q2 '23: 404.6M Q3 '23: 389.9M Q4 '23: 367.7M Q1 '24: 379.5M Q2 '24: 390.5M Q3 '24: 425.4M Q4 '24: 489.6M Q1 '25: 513.3M Q2 '25: 526.4M Q3 '25: 536M Q4 '25: 546M Q1 '26: 564.4M Q2 '26: 583.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-240M -160M -80M 0 80M 160M 240M Q3 '21: 28.6M Q4 '21: 22.7M Q1 '22: 10.6M Q2 '22: -7.1M Q3 '22: -62.3M Q4 '22: -92.8M Q1 '23: -205.3M Q2 '23: -231.9M Q3 '23: -215.9M Q4 '23: -233.2M Q1 '24: -147.1M Q2 '24: -139.1M Q3 '24: -133.6M Q4 '24: -99.1M Q1 '25: -178.3M Q2 '25: -199.4M Q3 '25: -196.1M Q4 '25: -187.3M Q1 '26: -83.8M Q2 '26: -45.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-240M -160M -80M 0 80M 160M 240M Q3 '21: 21.8M Q4 '21: 15.6M Q1 '22: 5.9M Q2 '22: -13.2M Q3 '22: -67.9M Q4 '22: -94.6M Q1 '23: -203.8M Q2 '23: -224.5M Q3 '23: -208.5M Q4 '23: -222.6M Q1 '24: -141.5M Q2 '24: -136.5M Q3 '24: -126.8M Q4 '24: -96M Q1 '25: -183.9M Q2 '25: -205.5M Q3 '25: -203.4M Q4 '25: -204.7M Q1 '26: -94.5M Q2 '26: -63.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 200M 400M 600M Q3 '21: 307.8M Q4 '21: 326.6M Q1 '22: 343.6M Q2 '22: 362.3M Q3 '22: 379.5M Q4 '22: 388.2M Q1 '23: 389.9M Q2 '23: 385.8M Q3 '23: 381.5M Q4 '23: 380M Q1 '24: 390.6M Q2 '24: 405.5M Q3 '24: 428.9M Q4 '24: 450.6M Q1 '25: 469.6M Q2 '25: 475.3M Q3 '25: 471M Q4 '25: 468.7M Q1 '26: 463.1M Q2 '26: 458.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-40M 0 40M 80M 120M Q3 '21: 107M Q4 '21: 111.4M Q1 '22: 96.5M Q2 '22: 74.5M Q3 '22: 64.3M Q4 '22: 50.5M Q1 '23: 18.3M Q2 '23: 5.1M Q3 '23: -18.8M Q4 '23: -31.8M Q1 '24: -21.5M Q2 '24: -20.4M Q3 '24: 6.3M Q4 '24: 24.2M Q1 '25: 13.9M Q2 '25: 9.7M Q3 '25: -8.8M Q4 '25: -9.7M Q1 '26: 19.6M Q2 '26: -5.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-70M -35M 0 35M 70M 105M Q3 '21: 94.4M Q4 '21: 97.2M Q1 '22: 83.2M Q2 '22: 50.9M Q3 '22: 30.1M Q4 '22: 16.4M Q1 '23: -21.9M Q2 '23: -30.4M Q3 '23: -46M Q4 '23: -58.6M Q1 '24: -43.9M Q2 '24: -42M Q3 '24: -15.1M Q4 '24: 5M Q1 '25: -3.8M Q2 '25: -7.8M Q3 '25: -25.1M Q4 '25: -29.7M Q1 '26: -3.6M Q2 '26: -26.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q3 '21: 64.8M Q4 '21: 65.9M Q1 '22: 63.9M Q2 '22: 64.1M Q3 '22: 64.2M Q4 '22: 64.4M Q1 '23: 64.5M Q2 '23: 64.8M Q3 '23: 65.1M Q4 '23: 65.4M Q1 '24: 65.3M Q2 '24: 65M Q3 '24: 65.5M Q4 '24: 66.2M Q1 '25: 66.4M Q2 '25: 67M Q3 '25: 67.7M Q4 '25: 68M Q1 '26: 68.4M Q2 '26: 69M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: 0.29 Q4 '21: 0.23 Q1 '22: 0.08 Q2 '22: -0.22 Q3 '22: -1.07 Q4 '22: -1.48 Q1 '23: -3.17 Q2 '23: -3.48 Q3 '23: -3.23 Q4 '23: -3.44 Q1 '24: -2.17 Q2 '24: -2.09 Q3 '24: -1.93 Q4 '24: -1.46 Q1 '25: -2.78 Q2 '25: -3.09 Q3 '25: -3.05 Q4 '25: -3.07 Q1 '26: -1.40 Q2 '26: -0.93 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.